Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 31 items for :

  • "antidiabetic drugs" x
Clear All
Zhenyu Liu Department of Clinical Medicine, Beijing Luhe Hospital, Capital Medical University, Tongzhou District, Beijing, China

Search for other papers by Zhenyu Liu in
Google Scholar
PubMed Close
,
Huixi Kong Department of Clinical Medicine, Beijing Shijitan Hospital, Capital Medical University, Haidian District, Beijing, China

Search for other papers by Huixi Kong in
Google Scholar
PubMed Close
, and
Baoyu Zhang Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Tongzhou District, Beijing, China

Search for other papers by Baoyu Zhang in
Google Scholar
PubMed Close

with T2DM ( 15 , 16 ). Thus, to optimize the treatment plan, antidiabetic drugs that can reduce SUA levels are required to achieve comprehensive control in patients with T2DM and hyperuricemia. Therefore, this review aimed to summarize how antidiabetic

Article Type:
Review Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-24-0070
Volume/Issue:
Volume 13: Issue 6
Open access
Eva Olga Melin Department of Clinical Sciences, Endocrinology and Diabetes, Lund University, Faculty of Medicine, Lund, Sweden
Department of Research and Development, Region Kronoberg, Växjö, Sweden
Region Kronoberg, Primary Care, Växjö, Sweden

Search for other papers by Eva Olga Melin in
Google Scholar
PubMed Close
,
Jonatan Dereke Department of Clinical Sciences Lund, Lund University, Faculty of Medicine, Diabetes Research Laboratory, Lund, Sweden

Search for other papers by Jonatan Dereke in
Google Scholar
PubMed Close
,
Maria Thunander Department of Clinical Sciences, Endocrinology and Diabetes, Lund University, Faculty of Medicine, Lund, Sweden
Department of Research and Development, Region Kronoberg, Växjö, Sweden
Department of Internal Medicine, Endocrinology and Diabetes, Central Hospital, Växjö, Sweden

Search for other papers by Maria Thunander in
Google Scholar
PubMed Close
, and
Magnus Hillman Department of Clinical Sciences Lund, Lund University, Faculty of Medicine, Diabetes Research Laboratory, Lund, Sweden

Search for other papers by Magnus Hillman in
Google Scholar
PubMed Close

the prevalence of self-reported depression, abdominal obesity, general obesity, physical inactivity, smoking, cardiovascular complications, antidepressants, oral antidiabetic drugs (OADs) in addition to insulin, lipid lowering drugs (LLDs) or

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0108
Volume/Issue:
Volume 7: Issue 6
Open access
Lisa Arnetz Departments of Endocrinology, Molecular Medicine and Surgery, Metabolism and Diabetes
Departments of Endocrinology, Molecular Medicine and Surgery, Metabolism and Diabetes

Search for other papers by Lisa Arnetz in
Google Scholar
PubMed Close
,
Neda Rajamand Ekberg Departments of Endocrinology, Molecular Medicine and Surgery, Metabolism and Diabetes
Departments of Endocrinology, Molecular Medicine and Surgery, Metabolism and Diabetes

Search for other papers by Neda Rajamand Ekberg in
Google Scholar
PubMed Close
,
Kerstin Brismar Departments of Endocrinology, Molecular Medicine and Surgery, Metabolism and Diabetes
Departments of Endocrinology, Molecular Medicine and Surgery, Metabolism and Diabetes

Search for other papers by Kerstin Brismar in
Google Scholar
PubMed Close
, and
Michael Alvarsson Departments of Endocrinology, Molecular Medicine and Surgery, Metabolism and Diabetes
Departments of Endocrinology, Molecular Medicine and Surgery, Metabolism and Diabetes

Search for other papers by Michael Alvarsson in
Google Scholar
PubMed Close

from all patients before inclusion in the study. Patients with T2D were allowed to take oral antidiabetic drugs (OADs). Exclusion criteria were insulin or glucocorticoid therapy. One male patient with T2D was excluded from the analyses before and after

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-15-0003
Volume/Issue:
Volume 4: Issue 2
Open access
Agnieszka Adamska Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Białystok, Bialystok, Poland

Search for other papers by Agnieszka Adamska in
Google Scholar
PubMed Close
,
Vitalii Ulychnyi Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Białystok, Bialystok, Poland

Search for other papers by Vitalii Ulychnyi in
Google Scholar
PubMed Close
,
Katarzyna Siewko Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Białystok, Bialystok, Poland

Search for other papers by Katarzyna Siewko in
Google Scholar
PubMed Close
,
Anna Popławska-Kita Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Białystok, Bialystok, Poland

Search for other papers by Anna Popławska-Kita in
Google Scholar
PubMed Close
,
Małgorzata Szelachowska Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Białystok, Bialystok, Poland

Search for other papers by Małgorzata Szelachowska in
Google Scholar
PubMed Close
,
Marcin Adamski Faculty of Computer Science, Bialystok University of Technology, Białystok, Poland

Search for other papers by Marcin Adamski in
Google Scholar
PubMed Close
,
Angelika Buczyńska Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland

Search for other papers by Angelika Buczyńska in
Google Scholar
PubMed Close
, and
Adam Jacek Krętowski Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Białystok, Bialystok, Poland
Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland

Search for other papers by Adam Jacek Krętowski in
Google Scholar
PubMed Close

.08 One antihypertensive drug (%) 20.5 12.5 0.2 Two antihypertensive drugs (%) 21.3 23.1 0.8 Three or more antihypertensive drugs (%) 27.7 42.9 0.1 One antidiabetic drug (%) 16.7 21.3 <0.01 Two antidiabetic

Article Type:
Research Article
Collections:
Adrenal
DOI:
https://doi.org/10.1530/EC-22-0074
Volume/Issue:
Volume 11: Issue 9
Open access
Clemens Kamrath Center of Child and Adolescent Medicine, Justus Liebig University, Giessen, Germany

Search for other papers by Clemens Kamrath in
Google Scholar
PubMed Close
,
Alexander Eckert German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany
Institute of Epidemiology and Medical Biometry, ZIBMT, Ulm University, Ulm, Germany

Search for other papers by Alexander Eckert in
Google Scholar
PubMed Close
,
Birgit Rami-Merhar Department of Pediatrics and Adolescent Medicine, Medical University Vienna, Vienna, Austria

Search for other papers by Birgit Rami-Merhar in
Google Scholar
PubMed Close
,
Sebastian Kummer Department of General Pediatrics, Neonatology and Pediatric Cardiology, Heinrich Heine University, Medical Faculty, Duesseldorf, Germany

Search for other papers by Sebastian Kummer in
Google Scholar
PubMed Close
,
Martin Wabitsch Center for Rare Endocrine Diseases, Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, Ulm University Medical Centre, Ulm, Germany

Search for other papers by Martin Wabitsch in
Google Scholar
PubMed Close
,
Katharina Laubner Division of Endocrinology and Diabetology, Department of Medicine II, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany

Search for other papers by Katharina Laubner in
Google Scholar
PubMed Close
,
Florian Kopp Forth Clinical Department of Medicine, Academic Teaching Hospital Augsburg, Augsburg, Germany

Search for other papers by Florian Kopp in
Google Scholar
PubMed Close
,
Silvia Müther Center for Pediatric Diabetology, DRK-Kliniken-Berlin Westend, Berlin, Germany

Search for other papers by Silvia Müther in
Google Scholar
PubMed Close
,
Steffen Mühldorfer Department for Gastroenterology, Endocrinology and Metabolic Diseases, Bayreuth University Hospital, Friedrich-Alexander University Erlangen-Nuremberg, Bayreuth, Germany

Search for other papers by Steffen Mühldorfer in
Google Scholar
PubMed Close
, and
Reinhard W Holl German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany
Institute of Epidemiology and Medical Biometry, ZIBMT, Ulm University, Ulm, Germany

Search for other papers by Reinhard W Holl in
Google Scholar
PubMed Close

ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, gamma‐glutamyltransferase; HDL, high-density lipoprotein; LDL, low-density lipoprotein; ns, not significant. Other antidiabetic drugs were taken by 15 (60%) patients with LD

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-22-0333
Volume/Issue:
Volume 12: Issue 3
Open access
Niels B Dalsgaard Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

Search for other papers by Niels B Dalsgaard in
Google Scholar
PubMed Close
,
Lærke S Gasbjerg Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Lærke S Gasbjerg in
Google Scholar
PubMed Close
,
Laura S Hansen Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

Search for other papers by Laura S Hansen in
Google Scholar
PubMed Close
,
Dennis S Nielsen Department of Food Science, Faculty of Science, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Dennis S Nielsen in
Google Scholar
PubMed Close
,
Torben S Rasmussen Department of Food Science, Faculty of Science, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Torben S Rasmussen in
Google Scholar
PubMed Close
, and
Filip K Knop Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Steno Diabetes Center Copenhagen, Gentofte, Denmark

Search for other papers by Filip K Knop in
Google Scholar
PubMed Close

. Gut microbiota and antidiabetic drugs: perspectives of personalized treatment in type 2 diabetes mellitus . Frontiers in Cellular and Infection Microbiology 2022 12 853771 . ( https://doi.org/10.3389/fcimb.2022.853771 ) 26 Vandeputte D Kathagen

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-24-0052
Volume/Issue:
Volume 13: Issue 7
Open access
Yi Chen Institute and Department of Endocrinology and Metabolism, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China

Search for other papers by Yi Chen in
Google Scholar
PubMed Close
,
Wen Zhang Institute and Department of Endocrinology and Metabolism, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China

Search for other papers by Wen Zhang in
Google Scholar
PubMed Close
,
Chi Chen Institute and Department of Endocrinology and Metabolism, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China

Search for other papers by Chi Chen in
Google Scholar
PubMed Close
,
Yuying Wang Institute and Department of Endocrinology and Metabolism, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China

Search for other papers by Yuying Wang in
Google Scholar
PubMed Close
,
Ningjian Wang Institute and Department of Endocrinology and Metabolism, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China

Search for other papers by Ningjian Wang in
Google Scholar
PubMed Close
, and
Yingli Lu Institute and Department of Endocrinology and Metabolism, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China

Search for other papers by Yingli Lu in
Google Scholar
PubMed Close

bone biopsies to reveal microscopic changes, bone tissue biopsies are difficult to obtain in such a large population. Thirdly, combinations of multiple antidiabetic drug treatments are very common in patients with T2DM. In this study, although the

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-21-0484
Volume/Issue:
Volume 11: Issue 3
Open access
Jothydev Kesavadev Jothydev’s Diabetes Research Centre, Trivandrum, Kerala, India

Search for other papers by Jothydev Kesavadev in
Google Scholar
PubMed Close
,
Pradeep Babu Sadasivan Pillai Jothydev’s Diabetes Research Centre, Trivandrum, Kerala, India

Search for other papers by Pradeep Babu Sadasivan Pillai in
Google Scholar
PubMed Close
,
Arun Shankar Jothydev’s Diabetes Research Centre, Trivandrum, Kerala, India

Search for other papers by Arun Shankar in
Google Scholar
PubMed Close
,
Gopika Krishnan Jothydev’s Diabetes Research Centre, Trivandrum, Kerala, India

Search for other papers by Gopika Krishnan in
Google Scholar
PubMed Close
, and
Sunitha Jothydev Jothydev’s Diabetes Research Centre, Trivandrum, Kerala, India

Search for other papers by Sunitha Jothydev in
Google Scholar
PubMed Close

, many patients will eventually require to be shifted to another class of oral antidiabetic agents or insulin therapy ( 2 , 3 ). DPP-4 inhibitors are a class of oral antidiabetic drugs which enhance the function of endogenous incretin and help with

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0100
Volume/Issue:
Volume 6: Issue 8
Open access
Yuan Fang Department of Epidemiology, School of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai, China

Search for other papers by Yuan Fang in
Google Scholar
PubMed Close
,
Xuehong Zhang Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA

Search for other papers by Xuehong Zhang in
Google Scholar
PubMed Close
,
Huilin Xu Center for Disease Control and Prevention of Minhang District, Shanghai, China

Search for other papers by Huilin Xu in
Google Scholar
PubMed Close
,
Stephanie A Smith-Warner Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA

Search for other papers by Stephanie A Smith-Warner in
Google Scholar
PubMed Close
,
Dongli Xu Center for Disease Control and Prevention of Minhang District, Shanghai, China

Search for other papers by Dongli Xu in
Google Scholar
PubMed Close
,
Hong Fang Center for Disease Control and Prevention of Minhang District, Shanghai, China

Search for other papers by Hong Fang in
Google Scholar
PubMed Close
, and
Wang Hong Xu Department of Epidemiology, School of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai, China

Search for other papers by Wang Hong Xu in
Google Scholar
PubMed Close

-Hemphill V Moeny DG Wysowski DK . Use of antidiabetic drugs in the U.S., 2003–2012 . Diabetes Care 2014 37 1367 – 1374 . ( https://doi.org/10.2337/dc13-2289 ) 24 Gaviria-Mendoza A Sanchez-Duque JA Medina-Morales DA Machado-Alba JE . Prescription

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0381
Volume/Issue:
Volume 7: Issue 12
Open access
Jan Kvasnička 3rd Department of Medicine, General University Hospital and 1st Faculty of Medicine, Charles University in Prague, Praha, Czech Republic

Search for other papers by Jan Kvasnička in
Google Scholar
PubMed Close
,
Ondřej Petrák 3rd Department of Medicine, General University Hospital and 1st Faculty of Medicine, Charles University in Prague, Praha, Czech Republic

Search for other papers by Ondřej Petrák in
Google Scholar
PubMed Close
,
Tomáš Zelinka 3rd Department of Medicine, General University Hospital and 1st Faculty of Medicine, Charles University in Prague, Praha, Czech Republic

Search for other papers by Tomáš Zelinka in
Google Scholar
PubMed Close
,
Judita Klímová 3rd Department of Medicine, General University Hospital and 1st Faculty of Medicine, Charles University in Prague, Praha, Czech Republic

Search for other papers by Judita Klímová in
Google Scholar
PubMed Close
,
Barbora Kološová 3rd Department of Medicine, General University Hospital and 1st Faculty of Medicine, Charles University in Prague, Praha, Czech Republic

Search for other papers by Barbora Kološová in
Google Scholar
PubMed Close
,
Květoslav Novák Department of Urology, General University Hospital and 1st Faculty of Medicine, Charles University in Prague, Praha, Czech Republic

Search for other papers by Květoslav Novák in
Google Scholar
PubMed Close
,
David Michalský 1st Department of Surgery, General University Hospital and 1st Faculty of Medicine, Charles University in Prague, Praha, Czech Republic

Search for other papers by David Michalský in
Google Scholar
PubMed Close
,
Jiří Widimský Jr 3rd Department of Medicine, General University Hospital and 1st Faculty of Medicine, Charles University in Prague, Praha, Czech Republic

Search for other papers by Jiří Widimský Jr in
Google Scholar
PubMed Close
, and
Robert Holaj 3rd Department of Medicine, General University Hospital and 1st Faculty of Medicine, Charles University in Prague, Praha, Czech Republic

Search for other papers by Robert Holaj in
Google Scholar
PubMed Close

with 24-h ambulatory blood pressure monitoring ( 21 ). Diabetes mellitus was defined as medication with oral antidiabetic drugs or repeated fasting glucose levels of ≥7.0 mmol/L ( 22 ). All subjects with dyslipidemia (LDL ≥3.0 mmol/L) were on a diet and

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-21-0462
Volume/Issue:
Volume 10: Issue 12
Open access